News
Aptamer Group and WuXi AppTec Research Service Division collaborate to identify new Optimer enabled therapeutics
Aptamer Group, the developer of Optimer therapeutics and diagnostics, and WuXi AppTec Research Service Division, an integrated chemistry and biology research platform, announce a research collaboration to identify new Optimer-enabled therapeutics.
The collaboration will aim to identify Optimers for use...
News
Top Industrialization Challenges of Gene Therapy Manufacturing
Manufacturing and scale-up of industrialized processes to manufacture gene therapy products are accompanied by many challenges that must be overcome to succeed in the marketplace. Commercialization of gene therapies for patient use is time consuming and requires substantial financial...
News
kintor pharmaceutical Receives EUA for Proxalutamide for the Treatment of COVID-19 in Paraguay
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that Paraguay's Ministry of Public Health and Social Welfare (MSPBS) has granted an emergency use authorization (EUA) for proxalutamide to treat hospitalized patients with...
News
UK to launch research studies to develop long Covid therapies
The UK Government has announced plans to commence a research programme comprising of 15 new studies to develop new therapies for long Covid and enhance diagnosis.
As per the National Institute for Health and Care Excellence (NICE) guidance, long Covid...
News
Kintor Pharm Collaborates with Fosun Pharma Development to Commercialise Proxalutamide for Treatment of COVID-19 in India and Africa
Kintor Pharmaceutical Limited announced that it has entered into a licensing agreement with Shanghai Fosun Pharmaceutical Development Ltd., on the commercialisation of proxalutamide for the treatment of Covid-19 indication in India and 28 African countries.
Kintor and Fosun Pharma Development...
News
Supporting Indian Biotherapeutic Companies with Antibody Development
Fusion Antibodies, pre-clinical antibody discovery and development experts and BioTickle, their exclusive distributor in India, are providing local biopharmaceutical organisations with access to invaluable unique biopharmaceutical development capabilities.
As Dr Richard Jones, CEO of Fusion Antibodies explains, "We are proud...
News
Cognizant Enhances its Smart Manufacturing Offerings with the Acquisition of TQS Integration
Cognizant announced it has agreed to acquire TQS Integration, a privately owned global industrial data and intelligence company based in Lismore, Ireland. TQS delivers manufacturing data intelligence, global technology consulting and digital systems integration to help manufacturers accelerate their...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















